AI could now become a vital component in cancer treatment
A new AI technology from 3SONIC, Rigshospitalet and DTU aims to support critical decision-making during cancer surgeries an innovation with the potential to save lives.
3SONIC & BETA.HEALTH: Advancing Precision in Cancer Surgery
Through the BETA.HEALTH program, we are validating and maturing the 3Sonic platform at Rigshospitalet. The goal is clear: providing surgeons with real-time 3D imaging in the OR to reduce repeat surgeries and improve survival rates.
"We want to remove all cancer tissue on the first attempt"
No patient should have to go through a second surgery due to missed cancer tissue. 3Sonic is developing the technology that allows surgeons to verify tumor margins with precise 3D ultrasound in under 10 minutes.
A simple ultrasound scan transformed into 3D images will help surgeons evaluate tumors directly in the operating room. The goal is faster, more precise, and more cost-effective treatment.
3SONIC: A Novel 3D Device to Improve Precision in Cancer Surgery
3SONIC addresses a critical healthcare gap by bringing fast, precise 3D ultrasound margin assessment into the operating room, ensuring no cancerous tissue is left behind during tumor resections.
